pre-seed
Stage
1
Investors
About
Meddenovo is a biotech company developing an AI-powered computational platform for the de novo design of cyclic peptide drug candidates, enabling rapid discovery of peptide therapeutics particularly for challenging targets in oncology, radiopharmaceuticals, and metabolic diseases.
Explore Meddenovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.